Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc.
Your view on EBM.V
Overview
What the company does, where it operates, and who runs it.
About Eastwood Bio-Medical Canada Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Youngsoo Kim
- Headquarters
- 4871 Shell Road, Richmond, BC, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Youngsoo Kim
- Headquarters
- 4871 Shell Road, Richmond, BC, CA
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity.
The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism.
Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Eastwood Bio-Medical Canada Inc., and the rating behind it. EBM.V last traded at C$0.64; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Eastwood Bio-Medical Canada Inc.. Starting points for Eastwood Bio-Medical Canada Inc.: beta -0.09 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Eastwood Bio-Medical Canada Inc.. Eastwood Bio-Medical Canada Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Eastwood Bio-Medical Canada Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Eastwood Bio-Medical Canada Inc.. Eastwood Bio-Medical Canada Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Eastwood Bio-Medical Canada Inc. valued side by side against its closest peers. Eastwood Bio-Medical Canada Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Eastwood Bio-Medical Canada Inc., and how their positions are changing. At a C$44.1M market value, institutional positions materially move Eastwood Bio-Medical Canada Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Eastwood Bio-Medical Canada Inc. executives and directors. Shares of Eastwood Bio-Medical Canada Inc. have traded between C$0.29 and C$1.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Eastwood Bio-Medical Canada Inc.. Eastwood Bio-Medical Canada Inc. is a C$44.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Eastwood Bio-Medical Canada Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Eastwood Bio-Medical Canada Inc.. Coverage tracks Eastwood Bio-Medical Canada Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.